TSRX

Trius Therapeutics IncCIK 1356857 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for TSRX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for TSRX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Fischer Seth H.Z.	Director	4	$0	$0	2013-09-11
MORNEAU MICHAEL	VPF and CAO	12	$0	$350.0K	2013-09-11
THOMPSON JOHN CRAIG	Chief Commercial Officer	6	$0	$0	2013-09-11
O'Leary Brendan	Director	11	$0	$0	2013-09-11
Prokocimer Philippe	Chief Medical Officer	20	$0	$310.5K	2013-09-11
Finn John	Chief Scientific Officer	24	$0	$248.5K	2013-09-11
Schmid John P.	Chief Financial Officer	14	$0	$21.2K	2013-09-11
Bartizal Ken	Chief Development Officer	13	$0	$315.6K	2013-09-11
Stein Jeffrey	President and Chief Executive	11	$0	$0	2013-09-11
Kjellson Nina S	Director	7	$0	$0	2013-09-11
Schroeder Theodore R	Director	7	$0	$0	2013-09-11
Onaitis Matthew	General Counsel	2	$0	$0	2013-09-11
ATWOOD BRIAN G	Director	7	$0	$0	2013-09-11
EASTHAM KARIN	Director	11	$0	$0	2013-09-11
TRUEX PAUL F	Director	8	$0	$0	2013-09-11
KABAKOFF DAVID S	Director	8	$0	$0	2013-09-11
KPCB PBD Founders Fund, LLC	10% Owner	1	$0	$0	2013-05-10
Stack Risa	Director	2	$0	$0	2013-05-10
KPCB PANDEMIC & BIO DEFENSE FUND LLC	10% Owner	1	$0	$0	2013-05-10
POWELL MICHAEL	Director, 10% Owner	8	$0	$172.5K	2012-03-26
Sofinnova Management VII, L.L.C.	10% Owner	2	$0	$0	2012-01-12

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
THOMPSON JOHN CRAIG	Chief Commercial Officer	D To issuer deriv	2013-09-11	2013-09-13	125,000	$7.37	$921.3K	0	SEC↗
THOMPSON JOHN CRAIG	Chief Commercial Officer	D To issuer deriv	2013-09-11	2013-09-13	150,000	$9.20	$1.38M	0	SEC↗
THOMPSON JOHN CRAIG	Chief Commercial Officer	D To issuer deriv	2013-09-11	2013-09-13	90,000	$8.70	$783.0K	0	SEC↗
Schroeder Theodore R	Director	D To issuer deriv	2013-09-11	2013-09-13	15,116	$5.93	$89.6K	0	SEC↗
Schroeder Theodore R	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$8.45	$101.4K	0	SEC↗
Schroeder Theodore R	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$5.24	$62.9K	0	SEC↗
Schroeder Theodore R	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$10.00	$120.0K	0	SEC↗
Schroeder Theodore R	Director	D To issuer deriv	2013-09-11	2013-09-13	15,000	$5.73	$86.0K	0	SEC↗
Kjellson Nina S	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$5.24	$62.9K	0	SEC↗
Kjellson Nina S	Director	D To issuer deriv	2013-09-11	2013-09-13	9,302	$12.21	$113.6K	0	SEC↗
Kjellson Nina S	Director	D To issuer deriv	2013-09-11	2013-09-13	15,000	$5.73	$86.0K	0	SEC↗
Kjellson Nina S	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$8.45	$101.4K	0	SEC↗
Kjellson Nina S	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$10.00	$120.0K	0	SEC↗
ATWOOD BRIAN G	Director	D To issuer deriv	2013-09-11	2013-09-13	9,302	$12.21	$113.6K	0	SEC↗
ATWOOD BRIAN G	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$10.00	$120.0K	0	SEC↗
ATWOOD BRIAN G	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$5.24	$62.9K	0	SEC↗
ATWOOD BRIAN G	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$8.45	$101.4K	0	SEC↗
ATWOOD BRIAN G	Director	D To issuer deriv	2013-09-11	2013-09-13	15,000	$5.73	$86.0K	0	SEC↗
Fischer Seth H.Z.	Director	D To issuer deriv	2013-09-11	2013-09-13	2,500	$5.73	$14.3K	0	SEC↗
Fischer Seth H.Z.	Director	D To issuer deriv	2013-09-11	2013-09-13	30,000	$6.99	$209.7K	0	SEC↗
Onaitis Matthew	General Counsel	D To issuer deriv	2013-09-11	2013-09-13	100,000	$5.83	$583.0K	0	SEC↗
KABAKOFF DAVID S	Director	D To issuer deriv	2013-09-11	2013-09-13	18,000	$8.45	$152.1K	0	SEC↗
KABAKOFF DAVID S	Director	D To issuer deriv	2013-09-11	2013-09-13	18,000	$5.24	$94.3K	0	SEC↗
KABAKOFF DAVID S	Director	D To issuer deriv	2013-09-11	2013-09-13	18,000	$10.00	$180.0K	0	SEC↗
KABAKOFF DAVID S	Director	D To issuer deriv	2013-09-11	2013-09-13	21,000	$5.73	$120.3K	0	SEC↗
Stein Jeffrey	President & CEO	D To issuer deriv	2013-09-11	2013-09-13	250,000	$8.70	$2.17M	0	SEC↗
Stein Jeffrey	President & CEO	D To issuer deriv	2013-09-11	2013-09-13	200,000	$10.00	$2.00M	0	SEC↗
Stein Jeffrey	President & CEO	D To issuer deriv	2013-09-11	2013-09-13	30,813	$12.21	$376.2K	0	SEC↗
Stein Jeffrey	President & CEO	D To issuer deriv	2013-09-11	2013-09-13	81,280	$12.98	$1.06M	0	SEC↗
Stein Jeffrey	President & CEO	D To issuer deriv	2013-09-11	2013-09-13	156,976	$12.21	$1.92M	0	SEC↗
Stein Jeffrey	President & CEO	D To issuer deriv	2013-09-11	2013-09-13	275,000	$7.37	$2.03M	0	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	D To issuer deriv	2013-09-11	2013-09-13	80,000	$9.50	$760.0K	0	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	D To issuer deriv	2013-09-11	2013-09-13	15,000	$8.35	$125.3K	0	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	D To issuer deriv	2013-09-11	2013-09-13	30,000	$7.37	$221.1K	0	SEC↗
Prokocimer Philippe	Chief Medical Officer	D To issuer deriv	2013-09-11	2013-09-13	150,000	$7.37	$1.11M	0	SEC↗
Prokocimer Philippe	Chief Medical Officer	D To issuer deriv	2013-09-11	2013-09-13	90,000	$8.70	$783.0K	0	SEC↗
Prokocimer Philippe	Chief Medical Officer	D To issuer deriv	2013-09-11	2013-09-13	16,569	$12.21	$202.3K	0	SEC↗
Prokocimer Philippe	Chief Medical Officer	D To issuer deriv	2013-09-11	2013-09-13	1,744	$12.21	$21.3K	0	SEC↗
Prokocimer Philippe	Chief Medical Officer	D To issuer deriv	2013-09-11	2013-09-13	50,000	$10.00	$500.0K	0	SEC↗
Bartizal Ken	Chief Development Officer	D To issuer deriv	2013-09-11	2013-09-13	40,000	$10.00	$400.0K	0	SEC↗
Bartizal Ken	Chief Development Officer	D To issuer deriv	2013-09-11	2013-09-13	6,395	$12.21	$78.1K	0	SEC↗
Bartizal Ken	Chief Development Officer	D To issuer deriv	2013-09-11	2013-09-13	16,569	$12.21	$202.3K	0	SEC↗
Bartizal Ken	Chief Development Officer	D To issuer deriv	2013-09-11	2013-09-13	75,000	$8.70	$652.5K	0	SEC↗
Bartizal Ken	Chief Development Officer	D To issuer deriv	2013-09-11	2013-09-13	90,000	$7.37	$663.3K	0	SEC↗
TRUEX PAUL F	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$5.24	$62.9K	0	SEC↗
TRUEX PAUL F	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$10.00	$120.0K	0	SEC↗
TRUEX PAUL F	Director	D To issuer deriv	2013-09-11	2013-09-13	12,403	$12.21	$151.4K	0	SEC↗
TRUEX PAUL F	Director	D To issuer deriv	2013-09-11	2013-09-13	15,000	$5.73	$86.0K	0	SEC↗
TRUEX PAUL F	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$8.45	$101.4K	0	SEC↗
Schmid John P.	Chief Financial Officer	D To issuer deriv	2013-09-11	2013-09-13	28,720	$12.21	$350.7K	0	SEC↗
Schmid John P.	Chief Financial Officer	D To issuer deriv	2013-09-11	2013-09-13	8,138	$12.21	$99.4K	0	SEC↗
Schmid John P.	Chief Financial Officer	D To issuer deriv	2013-09-11	2013-09-13	85,000	$8.70	$739.5K	0	SEC↗
Schmid John P.	Chief Financial Officer	D To issuer deriv	2013-09-11	2013-09-13	75,000	$10.00	$750.0K	0	SEC↗
Schmid John P.	Chief Financial Officer	D To issuer deriv	2013-09-11	2013-09-13	140,000	$7.37	$1.03M	0	SEC↗
O'Leary Brendan	Director	D To issuer deriv	2013-09-11	2013-09-13	15,000	$5.73	$86.0K	0	SEC↗
O'Leary Brendan	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$9.50	$114.0K	0	SEC↗
O'Leary Brendan	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$5.24	$62.9K	0	SEC↗
O'Leary Brendan	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$8.45	$101.4K	0	SEC↗
EASTHAM KARIN	Director	D To issuer deriv	2013-09-11	2013-09-13	6,000	$10.00	$60.0K	0	SEC↗
EASTHAM KARIN	Director	D To issuer deriv	2013-09-11	2013-09-13	17,441	$5.93	$103.4K	0	SEC↗
EASTHAM KARIN	Director	D To issuer deriv	2013-09-11	2013-09-13	15,000	$5.73	$86.0K	0	SEC↗
EASTHAM KARIN	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$8.45	$101.4K	0	SEC↗
EASTHAM KARIN	Director	D To issuer deriv	2013-09-11	2013-09-13	12,000	$5.24	$62.9K	0	SEC↗
Finn John	Chief Scientific Officer	D To issuer deriv	2013-09-11	2013-09-13	80,000	$7.37	$589.6K	0	SEC↗
Finn John	Chief Scientific Officer	D To issuer deriv	2013-09-11	2013-09-13	95,000	$8.70	$826.5K	0	SEC↗
Finn John	Chief Scientific Officer	D To issuer deriv	2013-09-11	2013-09-13	50,000	$10.00	$500.0K	0	SEC↗
Finn John	Chief Scientific Officer	D To issuer deriv	2013-09-11	2013-09-13	8,138	$12.21	$99.4K	0	SEC↗
Finn John	Chief Scientific Officer	D To issuer deriv	2013-09-11	2013-09-13	48,837	$12.21	$596.3K	0	SEC↗
Finn John	Chief Scientific Officer	D To issuer deriv	2013-09-11	2013-09-13	35,813	$12.98	$464.9K	0	SEC↗
THOMPSON JOHN CRAIG	Chief Commercial Officer	D To issuer	2013-09-11	2013-09-13	2,455	—	$0	0	SEC↗
KABAKOFF DAVID S	Director	D To issuer	2013-09-11	2013-09-13	106,081	—	$0	0	SEC↗
KABAKOFF DAVID S	Director	D To issuer	2013-09-11	2013-09-13	5,285	—	$0	0	SEC↗
Stein Jeffrey	President & CEO	D To issuer	2013-09-11	2013-09-13	210,457	—	$0	0	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	D To issuer	2013-09-11	2013-09-13	14,070	—	$0	0	SEC↗
Prokocimer Philippe	Chief Medical Officer	D To issuer	2013-09-11	2013-09-13	12,190	—	$0	0	SEC↗
Prokocimer Philippe	Chief Medical Officer	D To issuer	2013-09-11	2013-09-13	82,022	—	$0	0	SEC↗
Bartizal Ken	Chief Development Officer	D To issuer	2013-09-11	2013-09-13	96,400	—	$0	0	SEC↗
TRUEX PAUL F	Director	D To issuer	2013-09-11	2013-09-13	11,270	—	$0	0	SEC↗
Schmid John P.	Chief Financial Officer	D To issuer	2013-09-11	2013-09-13	107,639	—	$0	0	SEC↗
O'Leary Brendan	Director	D To issuer	2013-09-11	2013-09-13	21,302	—	$0	0	SEC↗
EASTHAM KARIN	Director	D To issuer	2013-09-11	2013-09-13	6,000	—	$0	0	SEC↗
EASTHAM KARIN	Director	D To issuer	2013-09-11	2013-09-13	12,114	—	$0	0	SEC↗
Finn John	Chief Scientific Officer	D To issuer	2013-09-11	2013-09-13	3,230	—	$0	0	SEC↗
Finn John	Chief Scientific Officer	D To issuer	2013-09-11	2013-09-13	166,860	—	$0	0	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-07-22	2013-07-23	1,000	$12.10	$12.1K	166,860	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-07-15	2013-07-16	3,500	$10.55	$36.9K	167,860	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-07-12	2013-07-12	5,000	$10.10	$50.5K	171,360	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	M Exercise deriv	2013-07-11	2013-07-12	20,000	—	$0	80,000	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	S Sale	2013-07-11	2013-07-12	20,000	$9.75	$195.0K	12,545	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	M Exercise	2013-07-11	2013-07-12	20,000	$4.00	$80.0K	32,545	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-07-11	2013-07-12	500	$9.32	$4.7K	176,360	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-07-10	2013-07-12	1,000	$8.58	$8.6K	176,860	SEC↗
Prokocimer Philippe	Chief Medical Officer	S Sale	2013-07-01	2013-07-01	2,000	$8.14	$16.3K	82,022	SEC↗
Bartizal Ken	Chief Development Officer	S Sale	2013-07-01	2013-07-01	2,000	$8.14	$16.3K	95,300	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-06-12	2013-06-12	3,000	$9.08	$27.2K	177,860	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-06-11	2013-06-11	1,000	$8.94	$8.9K	180,860	SEC↗
Bartizal Ken	Chief Development Officer	S Sale	2013-06-04	2013-06-04	2,000	$7.90	$15.8K	97,300	SEC↗
Prokocimer Philippe	Chief Medical Officer	S Sale	2013-06-03	2013-06-03	2,000	$7.75	$15.5K	84,022	SEC↗
Onaitis Matthew	General Counsel	A Award deriv	2013-05-31	2013-06-03	100,000	—	$0	100,000	SEC↗
Prokocimer Philippe	Chief Medical Officer	S Sale	2013-05-24	2013-05-28	12,000	$7.93	$95.2K	86,022	SEC↗
Bartizal Ken	Chief Development Officer	S Sale	2013-05-24	2013-05-28	12,000	$7.93	$95.2K	98,927	SEC↗
KABAKOFF DAVID S	Director	A Award deriv	2013-05-21	2013-05-23	21,000	—	$0	21,000	SEC↗
EASTHAM KARIN	Director	A Award deriv	2013-05-21	2013-05-23	15,000	—	$0	15,000	SEC↗
ATWOOD BRIAN G	Director	A Award deriv	2013-05-21	2013-05-23	15,000	—	$0	15,000	SEC↗
Schroeder Theodore R	Director	A Award deriv	2013-05-21	2013-05-23	15,000	—	$0	15,000	SEC↗
TRUEX PAUL F	Director	A Award deriv	2013-05-21	2013-05-23	15,000	—	$0	15,000	SEC↗
O'Leary Brendan	Director	A Award deriv	2013-05-21	2013-05-23	15,000	—	$0	15,000	SEC↗
Kjellson Nina S	Director	A Award deriv	2013-05-21	2013-05-23	15,000	—	$0	15,000	SEC↗
Fischer Seth H.Z.	Director	A Award deriv	2013-05-21	2013-05-23	2,500	—	$0	2,500	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	M Exercise deriv	2013-05-14	2013-05-16	20,000	—	$0	0	SEC↗
Bartizal Ken	Chief Development Officer	S Sale	2013-05-14	2013-05-16	12,000	$7.85	$94.2K	98,927	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-05-14	2013-05-16	5,000	$8.10	$40.5K	181,860	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	S Sale	2013-05-14	2013-05-16	20,000	$7.75	$155.0K	10,635	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	M Exercise	2013-05-14	2013-05-16	20,000	$4.00	$80.0K	30,635	SEC↗
Bartizal Ken	Chief Development Officer	S Sale	2013-05-14	2013-05-28	12,000	$7.85	$94.2K	110,927	SEC↗
Prokocimer Philippe	Chief Medical Officer	S Sale	2013-05-13	2013-05-15	12,000	$7.65	$91.8K	86,022	SEC↗
Prokocimer Philippe	Chief Medical Officer	S Sale	2013-05-13	2013-05-28	12,000	$7.65	$91.8K	98,022	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-05-10	2013-05-13	3,000	$7.48	$22.4K	186,860	SEC↗
Stack Risa	Director	J Other	2013-05-10	2013-05-13	591	—	$0	591	SEC↗
KPCB PBD Founders Fund, LLC	10% Owner	J Other	2013-05-10	2013-05-14	4,050	—	$0	10,095	SEC↗
KPCB PANDEMIC & BIO DEFENSE FU	10% Owner	J Other	2013-05-10	2013-05-14	680,850	—	$0	1,697,031	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-05-10	2013-06-11	3,000	$7.48	$22.4K	186,860	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-04-24	2013-04-26	500	$7.10	$3.5K	189,860	SEC↗
Fischer Seth H.Z.	Director	A Award deriv	2013-04-03	2013-04-04	30,000	—	$0	30,000	SEC↗
Finn John	Chief Scientific Officer	S Sale	2013-03-15	2013-03-18	1,500	$7.10	$10.7K	190,360	SEC↗
Finn John	Chief Scientific Officer	A Award deriv	2013-03-07	2013-03-11	80,000	—	$0	80,000	SEC↗
Bartizal Ken	Chief Development Officer	A Award deriv	2013-03-07	2013-03-11	90,000	—	$0	90,000	SEC↗
Stein Jeffrey	President and CEO	A Award deriv	2013-03-07	2013-03-11	275,000	—	$0	275,000	SEC↗
MORNEAU MICHAEL	VPF and CAO	A Award deriv	2013-03-07	2013-03-11	30,000	—	$0	30,000	SEC↗
Prokocimer Philippe	Chief Medical Officer	A Award deriv	2013-03-07	2013-03-11	150,000	—	$0	150,000	SEC↗
Schmid John P.	Chief Financial Officer	A Award deriv	2013-03-07	2013-03-11	140,000	—	$0	140,000	SEC↗
THOMPSON JOHN CRAIG	Chief Commercial Officer	A Award deriv	2013-03-07	2013-03-11	125,000	—	$0	125,000	SEC↗
Schmid John P.	CFO and Secretary	S Sale	2012-06-22	2012-06-25	1,800	$6.00	$10.8K	107,639	SEC↗
EASTHAM KARIN	Director	A Award deriv	2012-05-22	2012-05-24	12,000	—	$0	12,000	SEC↗
KABAKOFF DAVID S	Director	A Award deriv	2012-05-22	2012-05-24	18,000	—	$0	18,000	SEC↗
Kjellson Nina S	Director	A Award deriv	2012-05-22	2012-05-24	12,000	—	$0	12,000	SEC↗
TRUEX PAUL F	Director	A Award deriv	2012-05-22	2012-05-24	12,000	—	$0	12,000	SEC↗
Stack Risa	Director	A Award deriv	2012-05-22	2012-05-24	12,000	—	$0	12,000	SEC↗
Schroeder Theodore R	Director	A Award deriv	2012-05-22	2012-05-24	12,000	—	$0	12,000	SEC↗
O'Leary Brendan	Director	A Award deriv	2012-05-22	2012-05-24	12,000	—	$0	12,000	SEC↗
ATWOOD BRIAN G	Director	A Award deriv	2012-05-22	2012-05-24	12,000	—	$0	12,000	SEC↗
Stein Jeffrey	President and CEO	M Exercise deriv	2012-03-27	2012-03-28	38,462	—	$0	81,280	SEC↗
Schmid John P.	CFO and Secretary	M Exercise deriv	2012-03-27	2012-03-28	5,000	—	$0	28,720	SEC↗
EASTHAM KARIN	Director	M Exercise deriv	2012-03-27	2012-03-29	6,000	—	$0	6,000	SEC↗
Stein Jeffrey	President and CEO	M Exercise	2012-03-27	2012-03-28	38,462	$0.52	$20.0K	210,457	SEC↗
Schmid John P.	CFO and Secretary	M Exercise	2012-03-27	2012-03-28	5,000	$1.29	$6.5K	109,439	SEC↗
EASTHAM KARIN	Director	M Exercise	2012-03-27	2012-03-29	6,000	$3.50	$21.0K	18,114	SEC↗
Finn John	Chief Scientific Officer	M Exercise deriv	2012-03-26	2012-03-27	20,000	—	$0	35,813	SEC↗
POWELL MICHAEL	Director	M Exercise deriv	2012-03-26	2012-03-27	9,302	—	$0	0	SEC↗
O'Leary Brendan	Director	M Exercise deriv	2012-03-26	2012-03-28	12,000	—	$0	12,000	SEC↗
O'Leary Brendan	Director	M Exercise deriv	2012-03-26	2012-03-28	9,302	—	$0	0	SEC↗
Finn John	Chief Scientific Officer	M Exercise	2012-03-26	2012-03-27	20,000	$0.52	$10.4K	191,860	SEC↗
POWELL MICHAEL	Director	M Exercise	2012-03-26	2012-03-27	9,302	$1.29	$12.0K	9,302	SEC↗
O'Leary Brendan	Director	M Exercise	2012-03-26	2012-03-28	9,302	$1.29	$12.0K	9,302	SEC↗
O'Leary Brendan	Director	M Exercise	2012-03-26	2012-03-28	12,000	$4.00	$48.0K	21,302	SEC↗
Prokocimer Philippe	Chief Medical Officer	M Exercise deriv	2012-03-23	2012-03-27	6,244	—	$0	0	SEC↗
Prokocimer Philippe	Chief Medical Officer	M Exercise	2012-03-23	2012-03-27	6,244	$0.52	$3.2K	98,022	SEC↗
THOMPSON JOHN CRAIG	Chief Commercial Officer	A Award deriv	2012-03-08	2012-03-12	90,000	—	$0	90,000	SEC↗
Bartizal Ken	Chief Development Officer	A Award deriv	2012-03-08	2012-03-12	75,000	—	$0	75,000	SEC↗
Prokocimer Philippe	Chief Medical Officer	A Award deriv	2012-03-08	2012-03-12	90,000	—	$0	90,000	SEC↗
Finn John	Chief Scientific Officer	A Award deriv	2012-03-08	2012-03-12	95,000	—	$0	95,000	SEC↗
Schmid John P.	Chief Financial Officer	A Award deriv	2012-03-08	2012-03-12	85,000	—	$0	85,000	SEC↗
Stein Jeffrey	President and Chief Executiv	A Award deriv	2012-03-08	2012-03-12	250,000	—	$0	250,000	SEC↗
Schmid John P.	CFO and Secretary	S Sale	2012-03-01	2012-03-02	500	$5.04	$2.5K	104,439	SEC↗
MORNEAU MICHAEL	VP Finance & CAO	A Award deriv	2012-02-22	2012-03-12	15,000	—	$0	15,000	SEC↗
Schmid John P.	CFO and Secretary	S Sale	2012-02-02	2012-02-06	500	$5.63	$2.8K	104,939	SEC↗
POWELL MICHAEL	Director	S Sale	2012-01-19	2012-01-20	2,600	$5.64	$14.7K	113,100	SEC↗
POWELL MICHAEL	Director	S Sale	2012-01-18	2012-01-20	4,300	$5.56	$23.9K	115,700	SEC↗
POWELL MICHAEL	Director	S Sale	2012-01-17	2012-01-17	16,100	$5.43	$87.4K	120,000	SEC↗
Prokocimer Philippe	Chief Medical Officer	M Exercise deriv	2012-01-13	2012-01-18	4,000	—	$0	6,244	SEC↗
Prokocimer Philippe	Chief Medical Officer	M Exercise deriv	2012-01-13	2012-03-27	4,000	—	$0	6,244	SEC↗
POWELL MICHAEL	Director	S Sale	2012-01-13	2012-01-17	8,522	$5.46	$46.5K	136,100	SEC↗
Prokocimer Philippe	Chief Medical Officer	M Exercise	2012-01-13	2012-01-18	4,000	$0.52	$2.1K	85,070	SEC↗
Prokocimer Philippe	Chief Medical Officer	M Exercise	2012-01-13	2012-03-27	4,000	$0.52	$2.1K	91,778	SEC↗
Sofinnova Management VII, L.L.	10% Owner	J Other	2012-01-12	2012-01-17	3,615,572	—	$0	28	SEC↗
Sofinnova Management VII, L.L.	10% Owner	J Other	2012-01-12	2012-01-17	144,622	—	$0	144,622	SEC↗
POWELL MICHAEL	Director, 10% Owner	J Other	2012-01-12	2012-01-17	144,622	—	$0	144,622	SEC↗
POWELL MICHAEL	Director, 10% Owner	J Other	2012-01-12	2012-01-17	3,615,572	—	$0	28	SEC↗
Schmid John P.	CFO and Secretary	S Sale	2012-01-03	2012-01-04	700	$7.28	$5.1K	105,439	SEC↗